ANDA 84803, held by Lederle. Chlorpromazine Hydrochloride.
As of Nov 16, 2026, ANDA 84803 (Chlorpromazine Hydrochloride), held by Lederle, was first approved by FDA on Mar 16, 1972, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 16, 1972 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlorpromazine Hydrochloride10MG ยท tablet;oral | Chlorpromazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters